1. Home
  2. CRMD vs ECPG Comparison

CRMD vs ECPG Comparison

Compare CRMD & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • ECPG
  • Stock Information
  • Founded
  • CRMD 2006
  • ECPG 1998
  • Country
  • CRMD United States
  • ECPG United States
  • Employees
  • CRMD N/A
  • ECPG N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • ECPG Finance Companies
  • Sector
  • CRMD Health Care
  • ECPG Finance
  • Exchange
  • CRMD Nasdaq
  • ECPG Nasdaq
  • Market Cap
  • CRMD 849.8M
  • ECPG 806.1M
  • IPO Year
  • CRMD 2010
  • ECPG 1999
  • Fundamental
  • Price
  • CRMD $13.18
  • ECPG $37.25
  • Analyst Decision
  • CRMD Strong Buy
  • ECPG Strong Buy
  • Analyst Count
  • CRMD 6
  • ECPG 3
  • Target Price
  • CRMD $15.00
  • ECPG $62.67
  • AVG Volume (30 Days)
  • CRMD 1.7M
  • ECPG 292.9K
  • Earning Date
  • CRMD 05-06-2025
  • ECPG 05-07-2025
  • Dividend Yield
  • CRMD N/A
  • ECPG N/A
  • EPS Growth
  • CRMD N/A
  • ECPG N/A
  • EPS
  • CRMD 0.28
  • ECPG N/A
  • Revenue
  • CRMD $82,553,827.00
  • ECPG $1,380,750,000.00
  • Revenue This Year
  • CRMD $238.38
  • ECPG $21.70
  • Revenue Next Year
  • CRMD $53.52
  • ECPG $8.86
  • P/E Ratio
  • CRMD $47.48
  • ECPG N/A
  • Revenue Growth
  • CRMD N/A
  • ECPG 11.49
  • 52 Week Low
  • CRMD $3.61
  • ECPG $26.45
  • 52 Week High
  • CRMD $13.85
  • ECPG $51.77
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 69.49
  • ECPG 48.19
  • Support Level
  • CRMD $11.88
  • ECPG $37.18
  • Resistance Level
  • CRMD $12.90
  • ECPG $38.98
  • Average True Range (ATR)
  • CRMD 0.55
  • ECPG 0.88
  • MACD
  • CRMD -0.07
  • ECPG -0.37
  • Stochastic Oscillator
  • CRMD 90.00
  • ECPG 2.26

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.

Share on Social Networks: